A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma. [electronic resource]
Producer: 20160404Description: e0127246 p. digitalISSN:- 1932-6203
- Adolescent
- Child
- Child, Preschool
- Eflornithine -- adverse effects
- Etoposide -- adverse effects
- Female
- Humans
- Infant
- Male
- Neuroblastoma -- drug therapy
- Ornithine Decarboxylase -- metabolism
- Ornithine Decarboxylase Inhibitors -- adverse effects
- Phenotype
- Polyamines -- metabolism
- Recurrence
- Safety
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.